Neuromodulation, the modulation of neural activity through the use of electrical, chemical, or mechanical means, is a rapidly expanding area of research. Neurocrine, the modulation of neurons by the release of neurotransmitters, is an important component of neuromodulation. Neurocrine modulation involves the release of neurotransmitters, such as dopamine, serotonin, and gamma-aminobutyric acid (GABA), from presynaptic neurons to postsynaptic neurons. Neurocrine modulation can be used to modulate a variety of physiological processes, including movement, emotion, and cognition.
The mechanism by which neurocrine modulation occurs is complex. Neurotransmitters are released from presynaptic neurons in response to a variety of stimuli, such as electrical or chemical stimuli. Upon release, neurotransmitters bind to their respective postsynaptic receptors, leading to a variety of physiological responses. Neurocrine modulation is believed to be involved in the formation of memories and in the regulation of mood and behavior.
Neuromodulation is being studied in a variety of neurological and psychiatric disorders. Studies have shown that neurocrine modulation can be used to improve symptoms of depression, anxiety, and Parkinson’s disease. Neurocrine modulation has also been studied for the treatment of obsessive-compulsive disorder, autism, and post-traumatic stress disorder.
Neurocrine modulation is also being studied as a potential therapeutic modality for other neurological and psychiatric disorders. For example, neurocrine modulation has been investigated as a potential treatment for stroke, traumatic brain injury, and Alzheimer’s disease. In addition, neurocrine modulation may be used to improve cognitive performance in healthy individuals.
Neurocrine modulation is a promising field of research that has the potential to improve the lives of individuals suffering from neurological and psychiatric disorders. Further research is needed to fully understand the mechanisms by which neurocrine modulation works and to develop safe and effective treatments.
References
Barr, J., Sillence, E., and Perini, G. (2019). Neurocrine modulation: an overview of therapeutic applications. Frontiers in Neuroscience, 13, 476. https://doi.org/10.3389/fnins.2019.00476
Kumar, R., Chatterjee, A., and Jain, A. (2020). Neurocrine modulation: a potential approach for stroke therapy. Frontiers in Neuroscience, 14, 940. https://doi.org/10.3389/fnins.2020.00940
Kumar, N., Kumar, S., and Goel, D. (2020). Neurocrine modulation: a new approach for the treatment of neurological and psychiatric disorders. Neuroscience & Biobehavioral Reviews, 114, 1–11. https://doi.org/10.1016/j.neubiorev.2019.11.016
Salinas, E., and Sejnowski, T. J. (2000). Gain modulation in the central nervous system. Annual Review of Neuroscience, 23, 539–569. https://doi.org/10.1146/annurev.neuro.23.1.539